Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan - Medication, Order: Above Normal Medications

XMLWordPrintable

    • Type: EC eCQMs - Eligible Clinicians
    • Resolution: Done
    • Priority: Moderate
    • Component/s: Measure
    • CMS69v5/NQF0421
    • Hide
      The following medications: Phentermine resin, Phentermine Hydrochloride, Diethylpropion, Lorcaserin Hydrochloride, Phentermine/topiramate, bupropion hydrochloride/ Naltrexone Hydrochloride, Liraglutide were not included in the value set and should be added.

      https://ecqi.healthit.gov/ep/ecqms-2017-performance-period/preventive-care-and-screening-body-mass-index-bmi-screening-and

      The EWG recommended adding medications (Phentermine resin, Diethylpropion, Lorcaserin, Phentermine/topiramate, bupropion/ Naltrexone, Liraglutide) to the Above Normal Medications value set OID: 2.16.840.1.113883.3.600.1.1498 as they are appropriate to prescribe as a follow-up when a patient has an above normal BMI value; we will add the following codes that correspond with the medications: 1112982, 1112987, 124083, 1300706, 1302827, 1302839, 1302850, 1313059, 1808549, 1551468, 1598268, 803348, 803353, 826131, 826586, 826600, 826808, 826832, 826910, 826919, 900038, 968766, 978654, 978668.
      Show
      The following medications: Phentermine resin, Phentermine Hydrochloride, Diethylpropion, Lorcaserin Hydrochloride, Phentermine/topiramate, bupropion hydrochloride/ Naltrexone Hydrochloride, Liraglutide were not included in the value set and should be added. https://ecqi.healthit.gov/ep/ecqms-2017-performance-period/preventive-care-and-screening-body-mass-index-bmi-screening-and The EWG recommended adding medications (Phentermine resin, Diethylpropion, Lorcaserin, Phentermine/topiramate, bupropion/ Naltrexone, Liraglutide) to the Above Normal Medications value set OID: 2.16.840.1.113883.3.600.1.1498 as they are appropriate to prescribe as a follow-up when a patient has an above normal BMI value; we will add the following codes that correspond with the medications: 1112982, 1112987, 124083, 1300706, 1302827, 1302839, 1302850, 1313059, 1808549, 1551468, 1598268, 803348, 803353, 826131, 826586, 826600, 826808, 826832, 826910, 826919, 900038, 968766, 978654, 978668.
    • Hide
      After reviewing all of the medications in relation to CQM-748 our final recommendation is as follows:

      We will ad the following medications: to the Above Normal BMI Medications follow-up OID: 2.16.840.1.113883.3.600.1.1498
      1112982 Phentermine Hydrochloride 15 MG Disintegrating Oral Tablet
      1112987 Phentermine Hydrochloride 30 MG Disintegrating Oral Tablet
      124083 Phentermine Hydrochloride 37.5 MG Disintegrating Oral Tablet
      803348 Phentermine Hydrochloride 37.5 MG Oral Capsule
      803353 Phentermine Hydrochloride 37.5 MG Oral Tablet
      826131 Phentermine Hydrochloride 18.8 MG Oral Capsule
      826808 Phentermine Hydrochloride 37.5 MG Extended Release Oral Capsule
      826919 Phentermine Hydrochloride 8 MG Oral Tablet
      900038 Phentermine Hydrochloride 30 MG Oral Capsule
      968766 Phentermine Hydrochloride 15 MG Oral Capsule
      1302827 24 HR Phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule
      1302839 24 HR Phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule
      1302850 24 HR Phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule
      1313059 24 HR Phentermine 11.25MG / topiramate 69 MG Extended Release Oral Capsule
      826586 PHENTERMINE RESIN 15 MG Extended Release Oral Capsule
      826600 PHENTERMINE RESIN 15 MG Oral Capsule
      826832 PHENTERMINE RESIN 30 MG Extended Release Oral Capsule
      826910 PHENTERMINE RESIN 30 MG Oral Capsule
      978654 Diethylpropion Hydrochloride 25 MG Oral Tablet
      978668 24 HR Diethylpropion Hydrochloride 75 MG Extended Release Oral Tablet
      1300706 lorcaserin hydrochloride 10 MG Oral Tablet
      1808549 24 HR lorcaserin hydrochloride 20 MG Extended Release Oral Tablet
      Show
      After reviewing all of the medications in relation to CQM-748 our final recommendation is as follows: We will ad the following medications: to the Above Normal BMI Medications follow-up OID: 2.16.840.1.113883.3.600.1.1498 1112982 Phentermine Hydrochloride 15 MG Disintegrating Oral Tablet 1112987 Phentermine Hydrochloride 30 MG Disintegrating Oral Tablet 124083 Phentermine Hydrochloride 37.5 MG Disintegrating Oral Tablet 803348 Phentermine Hydrochloride 37.5 MG Oral Capsule 803353 Phentermine Hydrochloride 37.5 MG Oral Tablet 826131 Phentermine Hydrochloride 18.8 MG Oral Capsule 826808 Phentermine Hydrochloride 37.5 MG Extended Release Oral Capsule 826919 Phentermine Hydrochloride 8 MG Oral Tablet 900038 Phentermine Hydrochloride 30 MG Oral Capsule 968766 Phentermine Hydrochloride 15 MG Oral Capsule 1302827 24 HR Phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule 1302839 24 HR Phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule 1302850 24 HR Phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule 1313059 24 HR Phentermine 11.25MG / topiramate 69 MG Extended Release Oral Capsule 826586 PHENTERMINE RESIN 15 MG Extended Release Oral Capsule 826600 PHENTERMINE RESIN 15 MG Oral Capsule 826832 PHENTERMINE RESIN 30 MG Extended Release Oral Capsule 826910 PHENTERMINE RESIN 30 MG Oral Capsule 978654 Diethylpropion Hydrochloride 25 MG Oral Tablet 978668 24 HR Diethylpropion Hydrochloride 75 MG Extended Release Oral Tablet 1300706 lorcaserin hydrochloride 10 MG Oral Tablet 1808549 24 HR lorcaserin hydrochloride 20 MG Extended Release Oral Tablet

          Assignee:
          Mathematica EC eCQM Team (Inactive)
          Reporter:
          Joelencia Leflore
          Votes:
          0 Vote for this issue
          Watchers:
          4 Start watching this issue

            Created:
            Updated:
            Resolved: